Will tomorrow's medicines work for everyone?
- 26 October 2004
- journal article
- review article
- Published by Springer Nature in Nature Genetics
- Vol. 36 (11) , S34-S42
- https://doi.org/10.1038/ng1437
Abstract
Throughout much of the world, 'race' and 'ethnicity' are key determinants of health. For example, African Americans have, by some estimates, a twofold higher incidence of fatal heart attacks and a 10% higher incidence of cancer than European Americans, and South Asian- or Caribbean-born British are approximately 3.5 times as likely to die as a direct result of diabetes than are British of European ancestry. The health care that people receive also depends on 'race' and 'ethnicity'. African Americans are less likely to receive cancer-screening services and more likely to have late-stage cancer when diagnosed than European Americans. Health disparities such as these are one of the greatest social injustices in the developed world and one of the most important scientific and political challenges.Keywords
This publication has 94 references indexed in Scilit:
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- A vision for the future of genomics researchNature, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertensionKidney International, 2002
- Cellular calcium and sodium regulation, salt‐sensitivity and essential hypertension in African AmericansEthnicity & Health, 1996
- Reduced β2-receptor mediated vasodilation in African AmericansLife Sciences, 1995
- Differing Mechanisms of Action of Angiotensin-Converting Enzyme Inhibition in Black and White Hypertensive PatientsHypertension, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986